Banyere-cancer / ọgwụgwọ / ọgwụ / leukemia
Ọdịnaya
- 1 Ọgwụ akwadoro maka ọrịa leukemia
- 1.1 Ọgwụ akwadoro maka Nnukwu Lymphoblastic Leukemia (ALL)
- 1.2 Ngwakọta Ọgwụ E Ji Eji Ọrịa Lymphoblastic Leukemia (ALL)
- 1.3 Ọgwụ akwadoro maka Myeloid Leukemia Nnukwu (AML)
- 1.4 Njikọ Ọgwụ E Ji Myeloid Leukemia Nnukwu (AML)
- 1.5 Ọgwụ akwadoro maka Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- 1.6 Ọgwụ a kwadoro maka Lymphocytic Leukemia na-adịghị ala ala (CLL)
- 1.7 Ngwakọta ọgwụ ọjọọ ejiri na Lymphocytic Leukemia na-adịghị ala ala (CLL)
- 1.8 Ọgwụ akwadoro maka Myelogenous Leukemia na-adịghị ala ala (CML)
- 1.9 Ọgwụ akwadoro maka Mast Cell Ọrịa Leukemia
- 1.10 Ọgwụ akwadoro maka Meningeal Leukemia
Ọgwụ akwadoro maka ọrịa leukemia
Ibe akwukwo a deputara ogwu ogwu nke Food and Drug Administration (FDA) kwadoro maka oria leukemia. Ndepụta ahụ gụnyere aha njirimara na aha njirimara. Peeji a depụtakwara njikọ ọgwụ ndị a na-ejikarị na-arịa ọrịa kansa ọbara. Ndị ọgwụ ọ bụla na nchịkọta ahụ kwadoro FDA. Agbanyeghị, a naghị anabata ngwakọta ọgwụ n'onwe ha, mana a na-eji ya eme ihe.
Aha ọgwụ na-ejikọta na nchịkọta NCI Cancer Information Information. Enwere ike ịnwe ọgwụ eji agwọ ọrịa leukemia ndị edeghị ebe a.
Ọgwụ akwadoro maka Nnukwu Lymphoblastic Leukemia (ALL)
Arranon (Nelarabine)
Asparaginase Erwinia chrysanthemi
Asparlas (Calaspargase Pegol-mknl)
Besponsa (Inotuzumab Ozogamicin)
Blinatumomab
Blincyto (Blinatumomab)
Calaspargase Pegol-mknl
Cerubidine (Daunorubicin Hydrochloride)
Clofarabine
Efere (Clofarabine)
Cyclophosphamide
Cytarabine
Dasatinib
Daunorubicin Hydrochloride
Dexamethasone
Doxorubicin Hydrochloride
Erwinaze (Asparaginase Erwinia Chrysanthemi)
Gleevec (Imatinib Mesylate)
Iclusig (Ponatinib Hydrochloride)
Inotuzumab Ozogamicin
Imatinib Mesylate
Kymiah (Tisagenlecleucel)
Marqibo (Vincristine Sulfate Liposome) Nkem Osuigwe
Mercaptopurine
Methotrexate
Nelarabine
Oncaspar (Pegaspargase)
Pegaspargase
Ponatinib Hydrochloride
Prednisone
Purinethol (Mercaptopurine)
Purixan (Mercaptopurine)
Rubidomycin (Daunorubicin Hydrochloride)
Sprycel (Dasatinib)
Tisagenlecleucel
Trexall (Methotrexate)
Sọlfọ Vincristine
Vincristine Sulfate Liposome
Ngwakọta Ọgwụ E Ji Eji Ọrịa Lymphoblastic Leukemia (ALL)
Hyper-CVAD
Ọgwụ akwadoro maka Myeloid Leukemia Nnukwu (AML)
Arsenic Trioxide
Cerubidine (Daunorubicin Hydrochloride)
Cyclophosphamide
Cytarabine
Daunorubicin Hydrochloride
Daunorubicin Hydrochloride na Cytarabine Liposome
Daurismo (Glasdegib Maleate)
Dexamethasone
Doxorubicin Hydrochloride
Enasidenib Mesylate
Gemtuzumab Ozogamicin
Gilteritinib Fumarate
Glasdegib Maleate
PFS Idamycin (Idarubicin Hydrochloride)
Idarubicin Hydrochloride
Idhifa (Enasidenib Mesylate)
Ivosidenib
Midostaurin
Mitoxantrone Hydrochloride
Mylotarg (Gemtuzumab Ozogamicin)
Rubidomycin (Daunorubicin Hydrochloride)
Rydapt (Midostaurin)
Tabloid (Thioguanine)
Thioguanine
Tibsovo (Ivosidenib)
Trisenox (Arsenic Trioxide) Ọgwụgwụ
Venicexta (Venetoclax)
Venetoclax
Sọlfọ Vincristine
Vyxeos (Daunorubicin Hydrochloride na Cytarabine Liposome)
Xospata (Gilteritinib Fumarate)
Njikọ Ọgwụ E Ji Myeloid Leukemia Nnukwu (AML)
ADE
Ọgwụ akwadoro maka Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Elzonris (Tagraxofusp-erzs)
- Tagraxofusp-erzs
Ọgwụ a kwadoro maka Lymphocytic Leukemia na-adịghị ala ala (CLL)
Alemtuzumab
Ariza (Ofatumumab)
Bendamustine Hydrochloride
Bendeka (Bendamustine Hydrochloride)
Campath (Alemtuzumab)
Chlorambucil
Copiktra (Duvelisib)
Cyclophosphamide
Dexamethasone
Duvelisib
Fludarabine Phosphate
Gazyva (Obinutuzumab)
Ibrutinib
Idelalisib
Imbruvica (Ibrutinib)
Leukeran (Chlorambucil)
Mechlorethamine Hydrochloride
Mustargen (Mechlorethamine Hydrochloride) Mkpụrụ osisi
Obinutuzumab
Ofatumumab
Prednisone
Rituxan (Rituximab)
Rituxan Hycela (Rituximab na Hyaluronidase Mmadụ)
Rituximab
Rituximab na Hyaluronidase Human
Treanda (Bendamustine Hydrochloride)
Venicexta (Venetoclax)
Venetoclax
Zydelig (Idelalisib)
Ngwakọta ọgwụ ọjọọ ejiri na Lymphocytic Leukemia na-adịghị ala ala (CLL)
CHLORAMBUCIL-PREDNISONE
CVP
Ọgwụ akwadoro maka Myelogenous Leukemia na-adịghị ala ala (CML)
Asụsụ (Bosutinib)
Bosutinib
Busulfan
Adaba (Busulfan)
Cyclophosphamide
Cytarabine
Dasatinib
Dexamethasone
Gleevec (Imatinib Mesylate)
Hydrea (Hydroxyurea)
Hydroxyurea
Iclusig (Ponatinib Hydrochloride)
Imatinib Mesylate
Mechlorethamine Hydrochloride
Mustargen (Mechlorethamine Hydrochloride) Mkpụrụ osisi
Myleran (Busulfan)
Nilotinib
Omacetaxine Mepesuccinate
Ponatinib Hydrochloride
Sprycel (Dasatinib)
Synribo (Omacetaxine Mepesuccinate)
Tasigna (Nilotinib)
Ọgwụ akwadoro maka Hairy Cell Leukemia
Cladribine
Intron A (Ntughari Interferon Alfa-2b)
Lumoxiti (Moxetumomab Pasudotox-tdfk)
Moxetumomab Pasudotox-tdfk
Recombinant Interferon Alfa-2b
Ọgwụ akwadoro maka Mast Cell Ọrịa Leukemia
Midostaurin
Rydapt (Midostaurin)
Ọgwụ akwadoro maka Meningeal Leukemia
Cytarabine